Fried Frank's Representation of American Bioscience Reported in <em>The Daily Deal</em>

Fried Frank's Representation of American Bioscience Reported in The Daily Deal

The November 29th Daily Deal reports that Fried Frank acted as counsel to American Bioscience in its acquisition by American Pharmaceutical Partners Inc. American Bioscience, a privately held company, had been the largest shareholder in American Pharmaceutical Partners. The deal was valued at approximately $4.1 billion.

news-detail.inc